Mutations in BRCA1/2 and other panel genes in patients with metastatic breast cancer: association with patient and disease characteristics and effect on prognosis

PURPOSE Among patients with metastatic breast cancer (mBC), the frequency of germline mutations in cancer susceptibility genes and the clinical relevance of these mutations are unclear. In this study, a prospective cohort of patients with mBC was used to determine mutation rates for breast cancer (B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fasching, Peter Andreas (VerfasserIn) , Yadav, Siddhartha (VerfasserIn) , Hu, Chunling (VerfasserIn) , Wunderle, Marius (VerfasserIn) , Häberle, Lothar (VerfasserIn) , Hart, Steven N. (VerfasserIn) , Rübner, Matthias (VerfasserIn) , Polley, Eric C. (VerfasserIn) , Lee, Kun Y. (VerfasserIn) , Gnanaolivu, Rohan D. (VerfasserIn) , Hadji, Peyman (VerfasserIn) , Hübner, Hanna (VerfasserIn) , Tesch, Hans (VerfasserIn) , Ettl, Johannes (VerfasserIn) , Overkamp, Friedrich (VerfasserIn) , Lux, Michael P. (VerfasserIn) , Ekici, Arif B. (VerfasserIn) , Volz, Bernhard (VerfasserIn) , Uhrig, Sabrina (VerfasserIn) , Lüftner, Diana (VerfasserIn) , Wallwiener, Markus (VerfasserIn) , Müller, Volkmar (VerfasserIn) , Belleville, Erik (VerfasserIn) , Untch, Michael (VerfasserIn) , Kolberg, Hans-Christian (VerfasserIn) , Beckmann, Matthias W. (VerfasserIn) , Reis, André (VerfasserIn) , Hartmann, Arndt (VerfasserIn) , Janni, Wolfgang (VerfasserIn) , Wimberger, Pauline (VerfasserIn) , Taran, Florin-Andrei (VerfasserIn) , Fehm, Tanja (VerfasserIn) , Wallwiener, Diethelm (VerfasserIn) , Brucker, Sara (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Hartkopf, Andreas (VerfasserIn) , Couch, Fergus J. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 29, 2021
In: Journal of clinical oncology
Year: 2021, Jahrgang: 39, Heft: 15, Pages: 1619-1630
ISSN:1527-7755
DOI:10.1200/JCO.20.01200
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.20.01200
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/pdf/10.1200/JCO.20.01200
Volltext
Verfasserangaben:Peter A. Fasching, MD; Siddhartha Yadav, MD; Chunling Hu, PhD; Marius Wunderle, MD; Lothar Häberle, PhD; Steven N. Hart, PhD; Matthias Rübner, PhD; Eric C. Polley, PhD; Kun Y. Lee, PhD; Rohan D. Gnanaolivu, PhD; Peyman Hadji, MD; Hanna Hübner, PhD; Hans Tesch, MD; Johannes Ettl, MD; Friedrich Overkamp, MD; Michael P. Lux, MD; Arif B. Ekici, PhD; Bernhard Volz, PhD; Sabrina Uhrig, PhD; Diana Lüftner, MD; Markus Wallwiener, MD; Volkmar Müller, MD; Erik Belleville, PhD; Michael Untch, MD; Hans-Christian Kolberg, MD; Matthias W. Beckmann, MD; André Reis, MD; Arndt Hartmann, MD; Wolfgang Janni, MD; Pauline Wimberger, MD; Florin-Andrei Taran, MD; Tanja N. Fehm, MD; Diethelm Wallwiener, MD; Sara Y. Brucker, MD; Andreas Schneeweiss, MD; Andreas D. Hartkopf, MD; and Fergus J. Couch, PhD

MARC

LEADER 00000caa a2200000 c 4500
001 1787060349
003 DE-627
005 20240206093645.0
007 cr uuu---uuuuu
008 220125s2021 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO.20.01200  |2 doi 
035 |a (DE-627)1787060349 
035 |a (DE-599)KXP1787060349 
035 |a (OCoLC)1341438960 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Fasching, Peter Andreas  |d 1975-  |e VerfasserIn  |0 (DE-588)129068780  |0 (DE-627)388703040  |0 (DE-576)297477099  |4 aut 
245 1 0 |a Mutations in BRCA1/2 and other panel genes in patients with metastatic breast cancer  |b association with patient and disease characteristics and effect on prognosis  |c Peter A. Fasching, MD; Siddhartha Yadav, MD; Chunling Hu, PhD; Marius Wunderle, MD; Lothar Häberle, PhD; Steven N. Hart, PhD; Matthias Rübner, PhD; Eric C. Polley, PhD; Kun Y. Lee, PhD; Rohan D. Gnanaolivu, PhD; Peyman Hadji, MD; Hanna Hübner, PhD; Hans Tesch, MD; Johannes Ettl, MD; Friedrich Overkamp, MD; Michael P. Lux, MD; Arif B. Ekici, PhD; Bernhard Volz, PhD; Sabrina Uhrig, PhD; Diana Lüftner, MD; Markus Wallwiener, MD; Volkmar Müller, MD; Erik Belleville, PhD; Michael Untch, MD; Hans-Christian Kolberg, MD; Matthias W. Beckmann, MD; André Reis, MD; Arndt Hartmann, MD; Wolfgang Janni, MD; Pauline Wimberger, MD; Florin-Andrei Taran, MD; Tanja N. Fehm, MD; Diethelm Wallwiener, MD; Sara Y. Brucker, MD; Andreas Schneeweiss, MD; Andreas D. Hartkopf, MD; and Fergus J. Couch, PhD 
264 1 |c March 29, 2021 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.01.2022 
520 |a PURPOSE Among patients with metastatic breast cancer (mBC), the frequency of germline mutations in cancer susceptibility genes and the clinical relevance of these mutations are unclear. In this study, a prospective cohort of patients with mBC was used to determine mutation rates for breast cancer (BC) predisposition genes, to evaluate the clinical characteristics of patients with mutations, and to assess the influence of mutations on patient outcome. PATIENTS AND METHODS Germline DNA from 2,595 patients with mBC enrolled in the prospective PRAEGNANT registry was evaluated for mutations in cancer predisposition genes. The frequencies of mutations in known BC predisposition genes were compared with results from a prospective registry of patients with nonmetastatic BC sequenced using the same QIAseq method and with public reference controls. Associations between mutation status and tumor characteristics, progression-free survival, and overall survival were assessed. RESULTS Germline mutations in 12 established BC predisposition genes (including BRCA1 and BRCA2) were detected in 271 (10.4%) patients. A mutation in BRCA1 or BRCA2 was seen in 129 patients (5.0%). BRCA1 mutation carriers had a higher proportion of brain metastasis (27.1%) compared with nonmutation carriers (12.8%). Mutations were significantly enriched in PRAEGNANT patients with mBC compared with patients with nonmetastatic BC (10.4% v 6.6%, P < .01). Mutations did not significantly modify progression-free survival or overall survival for patients with mBC. CONCLUSION Multigene panel testing may be considered in all patients with mBC because of the high frequency of germline mutations in BRCA1/2 and other BC predisposition genes. Although the prognosis of mutation carriers and nonmutation carriers with mBC was similar, differences observed in tumor characteristics have implications for treatment and for future studies of targeted therapies. 
700 1 |a Yadav, Siddhartha  |e VerfasserIn  |4 aut 
700 1 |a Hu, Chunling  |e VerfasserIn  |4 aut 
700 1 |a Wunderle, Marius  |e VerfasserIn  |4 aut 
700 1 |a Häberle, Lothar  |e VerfasserIn  |4 aut 
700 1 |a Hart, Steven N.  |e VerfasserIn  |4 aut 
700 1 |a Rübner, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Polley, Eric C.  |e VerfasserIn  |4 aut 
700 1 |a Lee, Kun Y.  |e VerfasserIn  |4 aut 
700 1 |a Gnanaolivu, Rohan D.  |e VerfasserIn  |4 aut 
700 1 |a Hadji, Peyman  |e VerfasserIn  |4 aut 
700 1 |a Hübner, Hanna  |e VerfasserIn  |4 aut 
700 1 |a Tesch, Hans  |e VerfasserIn  |4 aut 
700 1 |a Ettl, Johannes  |e VerfasserIn  |4 aut 
700 1 |a Overkamp, Friedrich  |e VerfasserIn  |4 aut 
700 1 |a Lux, Michael P.  |e VerfasserIn  |4 aut 
700 1 |a Ekici, Arif B.  |e VerfasserIn  |4 aut 
700 1 |a Volz, Bernhard  |e VerfasserIn  |4 aut 
700 1 |a Uhrig, Sabrina  |e VerfasserIn  |4 aut 
700 1 |a Lüftner, Diana  |e VerfasserIn  |4 aut 
700 1 |a Wallwiener, Markus  |d 1980-  |e VerfasserIn  |0 (DE-588)134044827  |0 (DE-627)692043934  |0 (DE-576)27468327X  |4 aut 
700 1 |a Müller, Volkmar  |e VerfasserIn  |4 aut 
700 1 |a Belleville, Erik  |e VerfasserIn  |4 aut 
700 1 |a Untch, Michael  |e VerfasserIn  |4 aut 
700 1 |a Kolberg, Hans-Christian  |e VerfasserIn  |4 aut 
700 1 |a Beckmann, Matthias W.  |e VerfasserIn  |4 aut 
700 1 |a Reis, André  |e VerfasserIn  |4 aut 
700 1 |a Hartmann, Arndt  |e VerfasserIn  |4 aut 
700 1 |a Janni, Wolfgang  |e VerfasserIn  |4 aut 
700 1 |a Wimberger, Pauline  |d 1971-  |e VerfasserIn  |0 (DE-588)121614859  |0 (DE-627)705574733  |0 (DE-576)292800061  |4 aut 
700 1 |a Taran, Florin-Andrei  |e VerfasserIn  |4 aut 
700 1 |a Fehm, Tanja  |d 1971-  |e VerfasserIn  |0 (DE-588)120391759  |0 (DE-627)080645690  |0 (DE-576)292194064  |4 aut 
700 1 |a Wallwiener, Diethelm  |d 1954-  |e VerfasserIn  |0 (DE-588)121922413  |0 (DE-627)081622147  |0 (DE-576)16771726X  |4 aut 
700 1 |a Brucker, Sara  |d 1974-  |e VerfasserIn  |0 (DE-588)122129660  |0 (DE-627)081754264  |0 (DE-576)293107386  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Hartkopf, Andreas  |d 1979-  |e VerfasserIn  |0 (DE-588)139124101  |0 (DE-627)703216279  |0 (DE-576)309901596  |4 aut 
700 1 |a Couch, Fergus J.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 39(2021), 15, Seite 1619-1630  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnas  |a Mutations in BRCA1/2 and other panel genes in patients with metastatic breast cancer association with patient and disease characteristics and effect on prognosis 
773 1 8 |g volume:39  |g year:2021  |g number:15  |g pages:1619-1630  |g extent:12  |a Mutations in BRCA1/2 and other panel genes in patients with metastatic breast cancer association with patient and disease characteristics and effect on prognosis 
856 4 0 |u https://doi.org/10.1200/JCO.20.01200  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://ascopubs.org/doi/pdf/10.1200/JCO.20.01200  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220125 
993 |a Article 
994 |a 2021 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |d 50000  |e 910000PS109972554  |e 910400PS109972554  |e 50000PS109972554  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 35 
998 |g 121614859  |a Wimberger, Pauline  |m 121614859:Wimberger, Pauline  |p 29 
998 |g 134044827  |a Wallwiener, Markus  |m 134044827:Wallwiener, Markus  |d 910000  |d 910400  |d 50000  |e 910000PW134044827  |e 910400PW134044827  |e 50000PW134044827  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 20 
999 |a KXP-PPN1787060349  |e 4043181639 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1787060349"],"doi":["10.1200/JCO.20.01200"]},"physDesc":[{"extent":"12 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Mutations in BRCA1/2 and other panel genes in patients with metastatic breast cancer","title":"Mutations in BRCA1/2 and other panel genes in patients with metastatic breast cancer","subtitle":"association with patient and disease characteristics and effect on prognosis"}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"March 29, 2021"}],"relHost":[{"recId":"313116962","id":{"issn":["1527-7755"],"eki":["313116962"],"zdb":["2005181-5"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal","title_sort":"Journal of clinical oncology"}],"origin":[{"dateIssuedDisp":"1983-","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]","dateIssuedKey":"1983"}],"part":{"text":"39(2021), 15, Seite 1619-1630","extent":"12","pages":"1619-1630","issue":"15","year":"2021","volume":"39"},"language":["eng"],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"pubHistory":["1.1983 -"],"corporate":[{"role":"isb","display":"American Society of Clinical Oncology"}],"disp":"Mutations in BRCA1/2 and other panel genes in patients with metastatic breast cancer association with patient and disease characteristics and effect on prognosisJournal of clinical oncology","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}]}],"name":{"displayForm":["Peter A. Fasching, MD; Siddhartha Yadav, MD; Chunling Hu, PhD; Marius Wunderle, MD; Lothar Häberle, PhD; Steven N. Hart, PhD; Matthias Rübner, PhD; Eric C. Polley, PhD; Kun Y. Lee, PhD; Rohan D. Gnanaolivu, PhD; Peyman Hadji, MD; Hanna Hübner, PhD; Hans Tesch, MD; Johannes Ettl, MD; Friedrich Overkamp, MD; Michael P. Lux, MD; Arif B. Ekici, PhD; Bernhard Volz, PhD; Sabrina Uhrig, PhD; Diana Lüftner, MD; Markus Wallwiener, MD; Volkmar Müller, MD; Erik Belleville, PhD; Michael Untch, MD; Hans-Christian Kolberg, MD; Matthias W. Beckmann, MD; André Reis, MD; Arndt Hartmann, MD; Wolfgang Janni, MD; Pauline Wimberger, MD; Florin-Andrei Taran, MD; Tanja N. Fehm, MD; Diethelm Wallwiener, MD; Sara Y. Brucker, MD; Andreas Schneeweiss, MD; Andreas D. Hartkopf, MD; and Fergus J. Couch, PhD"]},"language":["eng"],"note":["Gesehen am 25.01.2022"],"person":[{"role":"aut","family":"Fasching","given":"Peter Andreas","display":"Fasching, Peter Andreas"},{"display":"Yadav, Siddhartha","given":"Siddhartha","role":"aut","family":"Yadav"},{"family":"Hu","role":"aut","display":"Hu, Chunling","given":"Chunling"},{"family":"Wunderle","role":"aut","given":"Marius","display":"Wunderle, Marius"},{"given":"Lothar","display":"Häberle, Lothar","family":"Häberle","role":"aut"},{"given":"Steven N.","display":"Hart, Steven N.","family":"Hart","role":"aut"},{"family":"Rübner","role":"aut","display":"Rübner, Matthias","given":"Matthias"},{"family":"Polley","role":"aut","display":"Polley, Eric C.","given":"Eric C."},{"display":"Lee, Kun Y.","given":"Kun Y.","family":"Lee","role":"aut"},{"display":"Gnanaolivu, Rohan D.","given":"Rohan D.","family":"Gnanaolivu","role":"aut"},{"family":"Hadji","role":"aut","display":"Hadji, Peyman","given":"Peyman"},{"family":"Hübner","role":"aut","given":"Hanna","display":"Hübner, Hanna"},{"display":"Tesch, Hans","given":"Hans","family":"Tesch","role":"aut"},{"display":"Ettl, Johannes","given":"Johannes","family":"Ettl","role":"aut"},{"role":"aut","family":"Overkamp","display":"Overkamp, Friedrich","given":"Friedrich"},{"family":"Lux","role":"aut","display":"Lux, Michael P.","given":"Michael P."},{"display":"Ekici, Arif B.","given":"Arif B.","family":"Ekici","role":"aut"},{"display":"Volz, Bernhard","given":"Bernhard","role":"aut","family":"Volz"},{"role":"aut","family":"Uhrig","display":"Uhrig, Sabrina","given":"Sabrina"},{"family":"Lüftner","role":"aut","display":"Lüftner, Diana","given":"Diana"},{"given":"Markus","display":"Wallwiener, Markus","role":"aut","family":"Wallwiener"},{"family":"Müller","role":"aut","display":"Müller, Volkmar","given":"Volkmar"},{"role":"aut","family":"Belleville","display":"Belleville, Erik","given":"Erik"},{"given":"Michael","display":"Untch, Michael","role":"aut","family":"Untch"},{"role":"aut","family":"Kolberg","given":"Hans-Christian","display":"Kolberg, Hans-Christian"},{"given":"Matthias W.","display":"Beckmann, Matthias W.","role":"aut","family":"Beckmann"},{"role":"aut","family":"Reis","given":"André","display":"Reis, André"},{"role":"aut","family":"Hartmann","given":"Arndt","display":"Hartmann, Arndt"},{"display":"Janni, Wolfgang","given":"Wolfgang","role":"aut","family":"Janni"},{"display":"Wimberger, Pauline","given":"Pauline","family":"Wimberger","role":"aut"},{"display":"Taran, Florin-Andrei","given":"Florin-Andrei","family":"Taran","role":"aut"},{"given":"Tanja","display":"Fehm, Tanja","family":"Fehm","role":"aut"},{"given":"Diethelm","display":"Wallwiener, Diethelm","family":"Wallwiener","role":"aut"},{"family":"Brucker","role":"aut","given":"Sara","display":"Brucker, Sara"},{"given":"Andreas","display":"Schneeweiss, Andreas","role":"aut","family":"Schneeweiss"},{"given":"Andreas","display":"Hartkopf, Andreas","role":"aut","family":"Hartkopf"},{"given":"Fergus J.","display":"Couch, Fergus J.","role":"aut","family":"Couch"}],"recId":"1787060349"} 
SRT |a FASCHINGPEMUTATIONSI2920